Support Provided ByLearn More
Body + BrainBody & Brain

"Perceptronium," Cyber Citizen Science, and RNAi: NOVA Next Week in Review

ByAllison EckNOVA NextNOVA Next

Receive emails about upcoming NOVA programs and related content, as well as featured reporting about current events through a science lens.

This Week’s NOVA Next Feature Article

TTR amyloidosis is debilitating and, even with today’s medicine, ultimately fatal. But there’s hope with a new therapy called RNAi.

Support Provided ByLearn More
NOVA Next contributor Cassandra Willyard reports that if it works, it could cure TTR amyloidosis and open new doors for the treatment of other diseases.

ALNY-lab1
In a lab in Cambridge, Massachusetts, researchers are racing to develop a cure for TTR amyloidosis.

In other news from NOVA and around the web:

Did you miss "Inside Animal Minds: Who’s the Smartest?" Stream it here—and remember, it will only be available for the next four weeks.

Photo courtesy Alnylam

Funding for NOVA Next is provided by the Eleanor and Howard Morgan Family Foundation.

National corporate funding for NOVA is provided by Draper. Major funding for NOVA is provided by the David H. Koch Fund for Science, the Corporation for Public Broadcasting, and PBS viewers. Additional funding is provided by the NOVA Science Trust.